National Drug Strategy
National Drug Strategy

Comorbidity of mental disorders and substance use: a brief guide for the primary care clinician

8.3 Major clinical issues with personality disorders and cannabis/ hallucinogen use

prev pageTOC |next page

Table of contents

8.3.1 Effects of cannabis and other hallucinogens on personality disorders

8.3.2 Interactions between cannabis and other hallucinogens and therapeutic agents for personality disorders

8.3.3 Management approaches to comorbid personality disorders and cannabis use

prev pageTOC |next page